Newest Solution For the Overweight

Are you overweight? Do you have blood sugars that are abnormal? Are your lipid tests abnormal (including cholesterol)? A new year is here with a new strategy to discuss with your gyno! A new medication indication, for weight loss, has been approved by the FDA for the diabetes medication liraglutide. This drug will be marketed as Saxenda, by the company Novo Nordisk, and now will be available for your primary care gyno to pick for you for the treatment of obesity, although anticipate that it may be a bit before this is available by prescription at your local pharmacy. It is a higher dosage than is prescribed for diabetes to affect weight loss. For decades we have realized that many medications are not weight neutral, but in fact promote obesity. Newer studies have discovered that some medicaitons make lifestyle changes more effective for weight loss, and some studies indicate, even without significant lifestyle factors such as exercise and activity with the right medication women can lose weight. AS reported in Medscape recently: Liraglutide now becomes the fifth available obesity drug in the United States, after orlistat (Xenical and Alli), lorcaserin (Belviq), phentermine-topiramate (Qsymia), and bupropion/naltrexone (Contrave). Other medications, such as phentermine are also used for weight loss in selective patients. The medication liraglutide has been associated with thyroid cancer in rodents, and is not for women with multiple endocrine cancers. It has been monitored for over a decade showing there is no breast cancer risk and there is a new study that is looking at long term heart risks (hopefully lower) and long term cancer risks called the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) study, investigating the 1.8-mg dose for cardiovascular risk as well as for neoplasms and other adverse events. That study is scheduled to conclude in 2016. Although early data shows that women could lose 44% in 16 weeks, by the end of a year of medication, the average loss is about 8% due to lapses in lifestyle changes.


Popular posts from this blog

Passing Your Uterine Lining, Menstrual Period Norms

Mirena IUD and Your Sex Drive

Post-Endometrial Ablation Syndrome